Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

For patients with out-of-hospital cardiac arrest (OHCA), the proportion receiving layperson bystander life support (BLS) has ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

I was 43 at the time. I had a busy job, with pressures and demands, trying to be a good dad and husband. But that’s the same ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Semaglutide can help lower the risk of cardiovascular complications in people with diabetes, a new study has found.

A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular events in people with established CVD and overweight or obesity without ...

A 50-year-old woman who 'died' for 24 minutes while on a school run has revealed what she felt and saw 'on the other side'.

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Four hundred airmen of the New York Air National Guard's 109th Airlift Wing have returned to Scotia after completing missions ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...